Avanos Medical
AVNS
AVNS was delisted on the 24th of July, 2026.
387 hedge funds and large institutions have $2.93B invested in Avanos Medical in 2018 Q3 according to their latest regulatory filings, with 110 funds opening new positions, 80 increasing their positions, 102 reducing their positions, and 41 closing their positions.
168% more first-time investments, than exits
New positions opened: 110 | Existing positions closed: 41
65% more call options, than puts
Call options by funds: $10.4M | Put options by funds: $6.34M
27% more capital invested
Capital invested by funds: $2.32B → $2.93B (+$615M)
21% more funds holding
Funds holding: 321 → 387 (+66)
4.49% more ownership
Funds ownership: 86.08% → 90.57% (+4.5%)
22% less repeat investments, than reductions
Existing positions increased: 80 | Existing positions reduced: 102
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$57.6M |
| 2 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$56.2M |
| 3 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
+$33.8M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$29.7M |
| 5 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
+$21.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PIM
Paradice Investment Management
Denver,
Colorado
|
-$50.4M |
| 2 |
Millennium Management
New York
|
-$25.7M |
| 3 |
CRCP
Copper Rock Capital Partners
Boston,
Massachusetts
|
-$16.6M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$13.8M |
| 5 |
Renaissance Technologies
New York
|
-$11.4M |
AVNS Hedge Fund Activity: Q3 2018 in Review
387 of the 4,391 institutional investors tracked by Wall St. Rank reported a position in Avanos Medical (AVNS) for Q3 2018, worth a combined $2.93B — up 27% from $2.32B a quarter earlier.
Buyers outnumbered sellers: 110 funds opened new AVNS positions and 41 closed out — a net gain of 69 holders — while 80 added to existing stakes and 102 trimmed.
The largest buyer was Wells Fargo, adding an estimated $57.6M. The largest seller was Paradice Investment Management, cutting an estimated $50.4M.
- 387 institutional investors held Avanos Medical (AVNS) as of Q3 2018, up from 321 in Q2 2018.
- Funds reported $2.93B of Avanos Medical stock for Q3 2018, up 27% quarter-over-quarter.
- 110 funds opened new Avanos Medical positions in Q3 2018 and 41 closed out, a net change of +69 holders.
- The largest Avanos Medical buyer in Q3 2018 was Wells Fargo, an estimated $57.6M added.
- The largest Avanos Medical seller in Q3 2018 was Paradice Investment Management, an estimated $50.4M sold.
Based on aggregated 13F filings for Q3 2018.